Advocate Advocacy Tools

Medicines for HIV, Viral Hepatitis, and STIs in LMICs: Forecasts of Global Demand for 2022-2026

For the global community to be able to achieve ambitious targets relating to the prevention and treatment of HIV, viral hepatitis and sexually transmitted infections (STIs), multiple types of medicines must be widely accessible to all affected populations in all countries.

The World Health Organization (WHO) released a report providing forecasts of future demand for medicines in low- and middle-income countries (LMICs) used in the fields of HIV, viral hepatitis and STIs. The report jointly presents medicines forecasts across three disease areas in recognition of the benefits of addressing HIV, viral hepatitis and STIs in a coordinated manner.

Medicines for HIV, viral hepatitis, and sexually transmitted infections in low- and middle-income countries: forecasts of global demand for 2022 – 2026

Source: WHO